The NEFRONA study evaluated atheromatous disease in the carotid and femoral territories in patients with chronic kidney disease (CKD) without previous cardiovascular disease (CVD). Between 2010 and 2012, the study recruited a total of 2,445 CKD patients, 937 at CKD stage 3,820 at CKD stage 4-5, and 688 on renal replacement therapy (RRT) from hospitals in Spain, as well as 559 control participants without CKD. Participants were assessed at baseline and followed up biannually over a four-year period.
Study design
Cohort, Cohort - clinical
Number of participants at first data collection
2,445 (CKD patients)
559 (control participants)
Age at first data collection
18 - 74 years (CKD patients)
18 - 74 years (control participants)
Participant year of birth
Varied (CKD patients)
Varied (control participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2010
Primary Institutions
University Hospital Arnau de Vilanova (Hospital Universitario Arnau de Vilanova)
Profile paper DOI
Funders
AbbVie
European Foundation for the Study of Diabetes (EFSD)
European Regional Development Fund (ERDF)
Fondo Europeo de Desarrollo Regional (FEDER)
National Institute of Health Carlos III (ISCIII)
Ongoing?
No
Data types collected
Engagement
Keywords